[go: up one dir, main page]

HK1124363A1 - Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof - Google Patents

Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof

Info

Publication number
HK1124363A1
HK1124363A1 HK09101102.4A HK09101102A HK1124363A1 HK 1124363 A1 HK1124363 A1 HK 1124363A1 HK 09101102 A HK09101102 A HK 09101102A HK 1124363 A1 HK1124363 A1 HK 1124363A1
Authority
HK
Hong Kong
Prior art keywords
transgenic mammal
utilization
high affinity
gene transferred
affinity antibody
Prior art date
Application number
HK09101102.4A
Other languages
English (en)
Inventor
Nobuo Sakaguchi
Original Assignee
Immunokick Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunokick Inc filed Critical Immunokick Inc
Publication of HK1124363A1 publication Critical patent/HK1124363A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
HK09101102.4A 2002-11-07 2009-02-06 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof HK1124363A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2002/011598 WO2004040969A1 (ja) 2002-11-07 2002-11-07 Ｇａｎｐ導入トランスジェニック哺乳動物及びその利用

Publications (1)

Publication Number Publication Date
HK1124363A1 true HK1124363A1 (en) 2009-07-10

Family

ID=32310234

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09101102.4A HK1124363A1 (en) 2002-11-07 2009-02-06 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof

Country Status (11)

Country Link
US (2) US7919674B2 (zh)
EP (1) EP1559318B1 (zh)
JP (1) JP4478577B2 (zh)
KR (1) KR100941905B1 (zh)
CN (2) CN100396699C (zh)
AT (1) ATE427654T1 (zh)
AU (2) AU2002343870A1 (zh)
CA (1) CA2504867C (zh)
DE (1) DE60327094D1 (zh)
HK (1) HK1124363A1 (zh)
WO (2) WO2004040969A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5628130B2 (ja) * 2005-09-30 2014-11-19 株式会社トランスジェニック Ｎ１，ｎ８−ジアセチルスペルミジンに対する高特異性モノクローナル抗体
JP5028020B2 (ja) * 2005-09-30 2012-09-19 株式会社トランスジェニック Ｎ１，ｎ８−ジアセチルスペルミジンに対する高特異性モノクローナル抗体
NZ592159A (en) * 2005-12-09 2012-12-21 Amc Amsterdam Means and methods for influencing the stability of antibody producing cells
JP4982847B2 (ja) * 2006-07-10 2012-07-25 国立大学法人 熊本大学 Ｇａｎｐによる癌抑制遺伝子の活性化方法
JP5716257B2 (ja) * 2009-02-06 2015-05-13 国立大学法人 熊本大学 胆管癌特異的糖鎖エピトープを認識するモノクローナル抗体
DK2646466T3 (en) * 2010-12-02 2017-06-06 Aimm Therapeutics Bv METHODS AND METHODS FOR MANUFACTURING HIGH EFFICIENCY ANTIBODIES
EP2754713B1 (en) * 2011-09-09 2019-07-10 Trans Genic Inc. ANTIBODY AGAINST MUTANT alpha-ACTININ-4
WO2014054675A1 (ja) * 2012-10-04 2014-04-10 国立大学法人京都大学 原発性アルドステロン症の検出方法及びモノクローナル抗体
JP6462632B2 (ja) * 2016-06-01 2019-01-30 株式会社トランスジェニック 変異型α−アクチニン−４に対する抗体
PL3521307T3 (pl) 2016-09-30 2023-04-24 Chiome Bioscience Inc. Sposób pozyskiwania przeciwciał
EP3581645B1 (en) 2017-02-10 2021-09-01 Chiome Bioscience Inc. Method for promoting diversification of antibody variable region

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418110A (en) 1982-06-21 1983-11-29 Minnesota Mining And Manufacturing Vapor-permeable retroreflective sheeting
AU739304B2 (en) * 1997-09-24 2001-10-11 Sankyo Company Limited Method of diagnosing metabolic bone diseases
US6372955B1 (en) * 1998-02-17 2002-04-16 Ortho Mcneil Pharmaceutical, Inc. Methods for Producing B cells and antibodies from H2-O modified transgenic mice
US6972125B2 (en) 1999-02-12 2005-12-06 Genetics Institute, Llc Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
WO2000050611A1 (fr) * 1999-02-24 2000-08-31 Sumitomo Electric Industries, Ltd. Proteines ganp
AR022952A1 (es) * 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
US7605238B2 (en) 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
JP2001078779A (ja) * 1999-09-17 2001-03-27 Sumitomo Electric Ind Ltd Ｃａｌｐｐ蛋白質、これをコードするポリヌクレオチドおよび抗体
GB0010191D0 (en) * 2000-04-26 2000-06-14 Cancer Res Campaign Tech Assays, methods and means

Also Published As

Publication number Publication date
CA2504867C (en) 2013-02-05
CN101240291B (zh) 2011-08-24
AU2003277620B2 (en) 2008-10-16
CA2504867A1 (en) 2004-05-21
CN1711018A (zh) 2005-12-21
EP1559318A1 (en) 2005-08-03
JP4478577B2 (ja) 2010-06-09
CN100396699C (zh) 2008-06-25
JPWO2004040971A1 (ja) 2006-03-02
DE60327094D1 (de) 2009-05-20
US20060236417A1 (en) 2006-10-19
US7919674B2 (en) 2011-04-05
WO2004040971A1 (ja) 2004-05-21
CN101240291A (zh) 2008-08-13
AU2002343870A1 (en) 2004-06-07
AU2003277620A1 (en) 2004-06-07
US20080233109A1 (en) 2008-09-25
KR100941905B1 (ko) 2010-02-11
ATE427654T1 (de) 2009-04-15
WO2004040969A1 (ja) 2004-05-21
EP1559318A4 (en) 2006-04-26
KR20050049490A (ko) 2005-05-25
EP1559318B1 (en) 2009-04-08

Similar Documents

Publication Publication Date Title
HK1124363A1 (en) Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof
HK1081598A1 (en) Treatment of huntington's disease with epa
DE60231708D1 (de) Somatische pluripotente Zellen
MY154009A (en) Anti-alpha v beta 6 antibodies
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
UA84407C2 (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
EP2341148A3 (en) Diagnosis and treatment of cancer
WO2002064748A8 (en) Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2005062977A3 (en) Prostate cancer specific internalizing human antibodies
HUP0302384A2 (hu) Sejtek bioenergia metabolizmusában szerepet játszó biokémiai vegyületeket tartalmazó készítmények és alkalmazásuk
AU6090799A (en) Transgenic c. elegans as a model organism for research into alzheimer's disease
AU2001245319A1 (en) Methods of treating diseases with activated protein c
SI1465927T1 (sl) Protitelesa proti BAG3 za uporabo pri raziskavi, diagnostiki in terapiji bolezni, ki vključujejo celično smrt
ATE475315T1 (de) Mittel zur biologischen bekämpfung pilzlicher pflanzenkrankheiten
PL367306A1 (pl) Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
AU2002358580A1 (en) Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
WO2002074921A3 (en) Methods for isolating proteins expressed by dendritic cells
ATE473009T1 (de) Hemmung der neurodegeneration
PT1401283E (pt) Controlo biológico de doenças de plantas
DE60031539D1 (de) Mutiertes nurr1 gen
AU2002307829A1 (en) Gene involved in v(d)j recombination and/or dna repair
AU2002330713A1 (en) Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
UA32131A (uk) Спосіб визначення активності хімази у біологічних рідинах

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20231102